Stay updated on CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial page.

Latest updates to the CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial page
- CheckyesterdayChange DetectedFooter changes: the HHS Vulnerability Disclosure link was removed and the Revision: v3.3.3 tag was added. These changes are limited to footer and metadata and do not affect the study content.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedRevision: v3.3.2 is shown, replacing the previous v3.3.1. This appears to be a minor frontend update that does not alter study details or functionality.SummaryDifference0.1%

- Check30 days agoChange DetectedAdded clarifications that publications are provided voluntarily and are automatically filled from PubMed, and noted Revision: v3.3.1. The prior language implying PubMed articles are automatically generated and may relate to the study results was removed.SummaryDifference0.2%

- Check37 days agoChange DetectedRemoval of the government funding status notice at the bottom of the page; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check52 days agoChange DetectedThe new screenshot shows only minor UI/layout adjustments with no updates to core trial data (title, conditions, interventions, eligibility criteria, primary outcomes, or enrollment). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check80 days agoChange DetectedThe page now includes an operating-status notice and a version update to v3.2.0, while removing the previous v3.1.0 reference.SummaryDifference3%

Stay in the know with updates to CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CaBozantinib in Advanced Renal Cell Carcinoma Clinical Trial page.